Arrowhead Pharmaceuticals (ARWR) Amortization - Intangibles (2010 - 2011)
Arrowhead Pharmaceuticals (ARWR) posted Amortization - Intangibles of $71618.0 for Q4 2011, up 18.47% on a QoQ basis from $60452.0 in Q3 2011, and up 18.47% year-over-year from $60452.0 in Q4 2010.
Arrowhead Pharmaceuticals (ARWR) Amortization - Intangibles (2010 - 2011) Analysis & Trends
Arrowhead Pharmaceuticals' Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $71618.0 for Q4 2011.
- Quarterly Amortization - Intangibles rose 18.47% year-over-year to $71618.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $252974.0 (changed N/A YoY) and the FY2011 annual result came in at $241808.0, changed 0.0% from the prior year.
- Amortization - Intangibles was $71618.0 for Q4 2011 at Arrowhead Pharmaceuticals, up from $60452.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $71618.0 in Q4 2011 and bottomed at $60452.0 in Q2 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 71,618.00 |
| Sep 30, 2011 | 60,452.00 |
| Jun 30, 2011 | 60,452.00 |
| Dec 31, 2010 | 60,452.00 |
| Sep 30, 2010 | 60,452.00 |
| Jun 30, 2010 | 60,452.00 |